Live Micron Technology Inc Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about
Follow Peak Bio, Inc.

Get SEC filing alerts via email and in your feed for Peak Bio, Inc.

PKBO

Peak Bio, Inc.

About Peak Bio, Inc.

Peak Bio is a clinical-stage biopharmaceutical company developing innovative cancer, inflammatory, and rare disease therapeutics. Its core focus is on antibody-drug conjugates (ADCs) utilizing proprietary payload platforms, including novel toxins targeting RNA splicing and immune modulation. The company aims to create targeted, differentiated treatments with improved efficacy and safety, leveraging advanced antibody technologies and strategic partnerships to address unmet medical needs in oncology and rare diseases.
This description was generated via AI from an annual report. Updated 9 months ago.

Latest SEC Filings from Peak Bio, Inc.

1
1
Peak Bio, Inc. Ppeak Bio Reports Significant Financial Changes, Pursues Merger with Akari Therapeutics

Via official filing (AI summary) | over 1 year ago | 0 comments